Switching to bictegravir/emtricitabine/tenofovir alafenamide maintained HIV-1 RNA suppression in participants with archived antiretroviral resistance including M184V/I.

.

OBJECTIVES: Studies 1878 and 1844 demonstrated non-inferior efficacy of switching

PMID: 31430369

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.